Welcome to the Utah Chapter of the American College of Cardiology
Welcome to the Utah Chapter of the American College of Cardiology
From Left: Sharon Dickinson PA-C, AACC; Teshia Sorensen PharmD, BCPS, AACC and CV Team State Liaison of the Utah Chapter of the American College of Cardiology; Marci Farquhar-Snow, NP, AACC; Nancy Lundy, NP, AACC
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- AI-Enabled CCTA Reveals Premature Plaque Burden in South AsiansSouth Asians (SA) in the United States carry a higher burden of atherosclerotic cardiovascular disease (ASCVD) than other ethnic groups, and standard risk prediction tools often fail to capture this elevated risk.
- ACCEL Lite: The Case For Medically Tailored MealsIn this interview, Matthew W. Martinez MD, FACC and Laurence S. Sperling, MD, FACC discuss “Prescribing Meals, Not Just Meds: The Case For Medically Tailored Mealsâ€.
- FDA Update: Agency Approves First Oral PCSK9 Inhibitor to Treat High CholesterolThe U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, to lower LDL cholesterol in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH).
- API-CAT Analysis: Recurrent VTE Uncommon, Associated With Poor Short-Term SurvivalRecurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival among patients with cancer-associated thrombosis on extended apixaban therapy after at least six months of anticoagulation treatment, according to a post-hoc analysis of the API-CAT trial published July 13 in Circulation.
- Protein Intake and Cardiovascular Health: Separating Signal From NoiseMedia attention to protein has increased and resulted in significant scrutiny. Many individuals are unsure of how much protein to consume and whether higher intakes, like those recommended for exercise, are safe for cardiovascular health.

Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.